DexCom (DXCM) Revenue — Quarter Ended Jun 30, 2024
Revenue for the quarter rose compared with the preceding quarter and also increased relative to the same quarter one year earlier. The sequential growth moderated from the prior period's pace.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q2
Revenue for the quarter rose compared with the preceding quarter and also increased relative to the same quarter one year earlier. The sequential growth moderated from the prior period's pace.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1B
Revenue reported for this quarter.
Quarter-over-quarter
+9.0%
Change from the immediately preceding quarter.
Year-over-year
+15.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $975M | +26.7% |
| Dec 31, 2023 | $1B | +26.9% |
| Mar 31, 2024 | $921M | +24.2% |
| Jun 30, 2024 | $1B | +15.3% |
Revenue performance
The reported revenue increased from the immediately preceding quarter, and was also higher than the same quarter a year ago.
Quarterly comparison
Compared with the prior quarter, revenue improved; compared with the same quarter a year earlier, revenue was also up. The rate of growth, however, was lower than in earlier quarters.
What to watch
The pace of revenue growth has slowed relative to earlier periods, which may warrant attention in future quarters.